# Eurofins Lancaster Laboratories, Inc - Inspection Records

Source: https://www.keypedia.com/companies/eurofins-lancaster-laboratories-inc/fdb282e8-01fc-4626-8794-1b7394ba0890

> Inspection records and compliance data for Eurofins Lancaster Laboratories, Inc in Lancaster, Pennsylvania. Access full analysis and detailed observations.

---

## Details

- Name: Eurofins Lancaster Laboratories, Inc
- FEI Number: 2513291
- City: Lancaster
- State: Pennsylvania
- Country Name: United States
- Address Line 1: 2425 New Holland Pike
- Zip Code: 17601
- Business Operations: API/FDF ANALYTICAL TESTING

## Related Documents

- [FDA Inspection 1284580 - Eurofins Lancaster Laboratories, Inc - 2025-09-23](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/d905bc5d-0d6c-4d5e-b731-266193c1d3d1) — source: FDA, date: September 23, 2025
- [FDA Inspection 1284580 - Eurofins Lancaster Laboratories, Inc - 2025-09-23](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/35146b05-5a24-4e26-8820-288e62f4209b) — classification: No Action Indicated (NAI), source: FDA, date: September 23, 2025
- [483 - Eurofins Lancaster Laboratories, Inc - 2025-08-26](https://www.keypedia.com/records/483/eurofins-lancaster-laboratories-inc/446b35d2-f9c4-42f5-9658-5d423765db1f) — source: FDA, date: August 26, 2025
- [FDA Inspection 1279557 - Eurofins Lancaster Laboratories, Inc - 2025-08-26](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/204a3e19-1058-4e10-b09a-d0d509c4df22) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 26, 2025
- [EIR - Eurofins Lancaster Laboratories, Inc - 2021-10-21](https://www.keypedia.com/records/eir/eurofins-lancaster-laboratories-inc/54ec3aa7-0ea2-469c-81e8-be7f1a979149) — source: FDA, date: October 21, 2021
- [FDA Inspection 1156933 - Eurofins Lancaster Laboratories, Inc - 2021-10-21](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/f3ad05fc-9ab4-40d0-b37f-c5f61e8ee8d5) — classification: No Action Indicated (NAI), source: FDA, date: October 21, 2021
- [FDA Inspection 1156933 - Eurofins Lancaster Laboratories, Inc - 2021-10-21](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/4d87f249-7742-43a1-954b-3158e3a5047a) — classification: No Action Indicated (NAI), source: FDA, date: October 21, 2021
- [FDA Inspection 1156933 - Eurofins Lancaster Laboratories, Inc - 2021-10-21](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/6d9dc317-2a02-43dc-bcba-6ff0360cc209) — classification: No Action Indicated (NAI), source: FDA, date: October 21, 2021
- [EIR - Eurofins Lancaster Laboratories, Inc - 2019-10-17](https://www.keypedia.com/records/eir/eurofins-lancaster-laboratories-inc/a77f65d3-030c-4ac5-ab0a-fc633dc327e7) — source: FDA, date: October 17, 2019
- [FDA Inspection 1113269 - Eurofins Lancaster Laboratories, Inc - 2019-10-17](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/0477d2bf-7889-495f-9b67-a075a013c867) — classification: No Action Indicated (NAI), source: FDA, date: October 17, 2019
- [FDA Inspection 1113269 - Eurofins Lancaster Laboratories, Inc - 2019-10-17](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/5c27ca64-d1ab-4e70-84d3-1cd41dd1b051) — classification: No Action Indicated (NAI), source: FDA, date: October 17, 2019
- [EIR - Eurofins Lancaster Laboratories, Inc - 2019-09-13](https://www.keypedia.com/records/eir/eurofins-lancaster-laboratories-inc/a3b9943b-3208-47cb-9588-8279e30fd8e6) — source: FDA, date: September 13, 2019
- [FDA Inspection 1106449 - Eurofins Lancaster Laboratories, Inc - 2019-09-13](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/51a1f2e6-5e75-4452-b409-285f118967eb) — classification: No Action Indicated (NAI), source: FDA, date: September 13, 2019
- [EIR - Eurofins Lancaster Laboratories, Inc - 2017-09-28](https://www.keypedia.com/records/eir/eurofins-lancaster-laboratories-inc/8ab6103e-1865-4b46-8af3-cc2f27c77ea8) — source: FDA, date: September 28, 2017
- [FDA Inspection 1029560 - Eurofins Lancaster Laboratories, Inc - 2017-09-28](https://www.keypedia.com/records/fda_inspections/eurofins-lancaster-laboratories-inc/5f4ad951-3983-4065-a6a1-3056bae2a886) — classification: No Action Indicated (NAI), source: FDA, date: September 28, 2017
- [EIR - Eurofins Lancaster Laboratories, Inc - 2015-06-19](https://www.keypedia.com/records/eir/eurofins-lancaster-laboratories-inc/dcf5bf45-8344-4397-8d3b-e05e0afea7f6) — source: FDA, date: June 19, 2015

## Related Companies

- [Viatris Inc.](https://www.keypedia.com/companies/viatris-inc/e65d242e-4279-4e07-992f-5f241792c2cf)
- [Kobo Products, Inc](https://www.keypedia.com/companies/kobo-products-inc/998595c1-1a50-4600-8360-16c81c7e6d7b)
- [Pacific BioLabs](https://www.keypedia.com/companies/pacific-biolabs/3b9d5ef3-bc95-4934-9be0-40c8534a1bde)
- [Astellas Pharma US Inc.](https://www.keypedia.com/companies/astellas-pharma-us-inc/3bb1b330-7226-4071-b93b-2854ea7577cb)
- [SEAGEN INC.](https://www.keypedia.com/companies/seagen-inc/07c5dcb3-661e-4212-adfc-a00316850e38)
- [Meridian Medical Technologies, LLC a Subsidiary of Kindeva Drug Delivery, L.P.](https://www.keypedia.com/companies/meridian-medical-technologies-llc-a-subsidiary-of-kindeva-drug-delivery-lp/00b844de-fb09-432d-96ab-31b8f7192a5d)
- [Lloyd Inc. of Iowa](https://www.keypedia.com/companies/lloyd-inc-of-iowa/b4573054-1b28-4619-88ea-c42615aede75)
- [WuXi AppTec Inc.](https://www.keypedia.com/companies/wuxi-apptec-inc/9d289339-3edc-4d2e-aacb-4d849335e75d)
- [New Jersey Laboratories](https://www.keypedia.com/companies/new-jersey-laboratories/d310e635-49c8-4881-97d4-757fe831e691)
- [Curia New Jersey, LLC](https://www.keypedia.com/companies/curia-new-jersey-llc/3487be34-bea7-4920-8489-0c360d8868f0)

## Related Officers

- [Investigator](https://www.keypedia.com/people/anita-r-michael/b7699b1a-4157-477e-8226-2cfc906fc61d)
- [company_representative](https://www.keypedia.com/people/jeanine-schreiber/0805a895-204d-44ec-8d27-a85a25a36cd8)
- [Investigator ](https://www.keypedia.com/people/thomas-e-friel/205f23ee-8648-46d1-8485-11977a27e8e4)
- [Bradley E. Benasutti](https://www.keypedia.com/people/bradley-e-benasutti/7a03a364-ad6f-4a80-8504-3fbddc50af58)
- [company_representative](https://www.keypedia.com/people/gary-siko/7ba44bcb-e182-45e2-ac39-df231b7bf315)